Rigel Pharmaceuticals GAAP EPS of $1.46 beats by $0.56, revenue of $69.46M beats by $7.58M

2 hours ago 1

Rigel Pharmaceuticals press release (RIGL): Q3 GAAP EPS of $1.46 beats by $0.56.
Revenue of $69.46M (+25.6% Y/Y) beats by $7.58M.
Third quarter 2025 total revenue of approximately $69.5 million, including record net product sales of $64.1 million and contract revenues from collaborations